Appendix 3B: issue of unlisted options

On 10 March 2014, Invion issued 14,987,50 unlisted share options to staff and consultants to the company. Options have an exercise price of $0.12 and an expiry date of 9 November 2018.

9,187,500 Share Options will vest in accordance with pre-determined clinical development milestones.

5,800,000 Share Options will vest on the following dates and in the following proportions:

9 October 2014: (20%)
9 October 2015: (20%)
9 October 2016: (20%)
9 October 2017: (20%)
9 October 2018: (20%)

An Appendix 3B accompanies this announcement.

Posted in ASX Releases